Beobachten
- Pressemitteilung BoxID 402171
- Newsroom
- Media Monitor
Lippke/MOCON announces permeation, sterile medical packaging conferences
(PresseBox) (Neuwied, )
Two new one-day packaging conferences have been announced by Paul Lippke Handels-GmbH, Neuwied, Germany, a wholly-owned division of MOCON, Inc. (NASDAQ: MOCO), Minneapolis, Minn., USA.
The Latest Developments and Future Trends in Permeation Measurement (22 March) and Avoiding Failures in Sterile Medical Packaging (23 March) will be held at the Schloss Montabaur in Montabaur, Germany.
"As a leading provider of permeation measurement and package testing instrumentation, Lippke is well-versed in the latest package testing technology and is ideally suited to provide training seminars in these subject areas," said Franz Sturm, managing director, Lippke.
The permeation measurement event will include the following topics: basics and trends; a review of ASTM standards; shelf-life studies; high-barrier plastic films; high-temperature testing; quality results; and rapid food safety tests for bacterial detection.
The sterile medical program will provide an overview of sterile medical packaging and a review of package testing options, including a demonstration workshop. Several legal/regulatory topics will be covered including integrity testing as an alternative to sterility testing and ISO 11607 testing standards.
The conference will be conducted in English and the participation fee is 290 Euros for each seminar. The fee includes presentation materials, lunch and refreshments. For a detailed agenda and additional registration information please visit: www.lippke.com.
About MOCON
MOCON is a leading provider of instrumentation and consulting and laboratory services to medical, pharmaceutical, food and other industries worldwide. See www.mocon.com for more information.
This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include but are not limited to: uncertainties relating to competition and technological change, setbacks in product development program, slower-than-anticipated customer acceptance of new products, dependence on certain key industries, risk associated with the Company's acquisition strategy and international operations, and other factors set forth in the Company's filing with the Securities and Exchange Commission.
The Latest Developments and Future Trends in Permeation Measurement (22 March) and Avoiding Failures in Sterile Medical Packaging (23 March) will be held at the Schloss Montabaur in Montabaur, Germany.
"As a leading provider of permeation measurement and package testing instrumentation, Lippke is well-versed in the latest package testing technology and is ideally suited to provide training seminars in these subject areas," said Franz Sturm, managing director, Lippke.
The permeation measurement event will include the following topics: basics and trends; a review of ASTM standards; shelf-life studies; high-barrier plastic films; high-temperature testing; quality results; and rapid food safety tests for bacterial detection.
The sterile medical program will provide an overview of sterile medical packaging and a review of package testing options, including a demonstration workshop. Several legal/regulatory topics will be covered including integrity testing as an alternative to sterility testing and ISO 11607 testing standards.
The conference will be conducted in English and the participation fee is 290 Euros for each seminar. The fee includes presentation materials, lunch and refreshments. For a detailed agenda and additional registration information please visit: www.lippke.com.
About MOCON
MOCON is a leading provider of instrumentation and consulting and laboratory services to medical, pharmaceutical, food and other industries worldwide. See www.mocon.com for more information.
This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include but are not limited to: uncertainties relating to competition and technological change, setbacks in product development program, slower-than-anticipated customer acceptance of new products, dependence on certain key industries, risk associated with the Company's acquisition strategy and international operations, and other factors set forth in the Company's filing with the Securities and Exchange Commission.
Über Paul Lippke Handels-GmbH
Paul Lippke Handels-GmbH, a MOCON company, is the premier European provider of innovative testing instruments and laboratory services to the packaging, pharmaceutical, food and medical device industries. See www.lippke.com for further information.
Diese Pressemitteilungen könnten Sie auch interessieren
|
Avnet Technology Solutions EMEA erhielt Auszeichnungen 'Best Distributor of the Year' und 'Best VSPEX Distributor' bei den EMC EMEA Velocity Solution Provider Awards
, FirmenIntern, Avnet Technology Solutions GmbH
Avnet Technology Solutions, ein führendes, global agierendes Distributionsunternehmen für IT Lösungen, und operativer Bereich der Avnet, Inc. (NYSE: AVT), gewann...
|
Die Region im Fokus der Investoren - A³ auf dem ersten Europäischen Metropolregionen-Dialog
, FirmenIntern, Regio Augsburg Wirtschaft GmbH
Rund 130 Vertreter der Immobilienwirtschaft und öffentlichen Hand erörterten am 14. Mai 2013 im Literaturhaus München die Entwicklungsperspektiven und Projekte in...
|
Neuer Leiter Forschung & Entwicklung bei SurTec
, FirmenIntern, SurTec Deutschland GmbH
Mit Wirkung vom 1. April 2013 übernimmt Herr Dr. Jochen Heber die Position als Leiter Forschung & Entwicklung Galvanotechnik der SurTec International GmbH. Er zeichnet...
